Cargando…
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
BACKGROUND: The interleukin-13 receptor alpha 2 (IL13RA2) and ephrin type A receptor 2 (EPHA2) are attractive therapeutic targets, being expressed in ~90% of canine and human gliomas, and absent in normal brain. Clinical trials using an earlier generation IL-13 based cytotoxin showed encouraging cli...
Autores principales: | Rossmeisl, John H, Herpai, Denise, Quigley, Mindy, Cecere, Thomas E, Robertson, John L, D’Agostino, Ralph B, Hinckley, Jonathan, Tatter, Stephen B, Dickinson, Peter J, Debinski, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992889/ https://www.ncbi.nlm.nih.gov/pubmed/32812637 http://dx.doi.org/10.1093/neuonc/noaa196 |
Ejemplares similares
-
Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020) -
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
por: Debinski, Waldemar, et al.
Publicado: (2013) -
Simultaneous targeting of Eph receptors in glioblastoma
por: Ferluga, Sara, et al.
Publicado: (2016) -
IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017) -
Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
por: Rodriguez, Analiz, et al.
Publicado: (2015)